Spend the Summer Outside With Fairmount Park Conservancy’s Packed Wellness Events Calendar
Including yoga, bootcamps, sound meditation, and scavenger hunts.
NextUp: The Navy Yard-Based Biopharma Company Engineering T-Cell Receptors to Destroy Cancerous Solid Tumors
After promising Phase II data, Adaptimmune is on track to file their drug candidate, afami-cel, for FDA approval next year.
The First FDA-Approved Cell Therapy for Multiple Myeloma Is Now Being Offered at Fox Chase
The Northeast Philadelphia cancer center will offer Abecma — a CAR T-cell therapy targeting myeloma cells — to patients who have previously tried at least four different treatments.
CHOP Launched a Grief and Trauma Support Program for Philly Kids
The new collaboration between CHOP, the Netter Center, and Uplift seeks to help children in West and Southwest Philly and their families cope with trauma from community violence and the pandemic.
How Fox Chase’s Evelyn González Is Fighting Cancer Care Disparities in Philly
The Fox Chase Cancer Center senior director of community outreach recently co-authored a paper on ways to decrease cancer care disparities in medically underserved communities in America.
Penn Just Launched a Neurological Clinic for COVID-19 Long Haulers
The Penn Neuro COVID Clinic provides evaluations, screenings, and referrals for COVID-related neurological complications like brain fog and vertigo.
NextUp: The UCity Biotech Company Using Tissue-Targeting Technology to Deliver Genetic Medicine
Aro Biotherapeutics’ gene medicine platform uses Centyrin, an engineered human protein, to attack and treat disease with more precision.
The Philly Biotech Company Developing an In Vivo Approach to CAR T-Cell Therapy
Interius BioTherapeutics just raised $76 million in seed funding to advance their clinical testing.
A Penn Doctor Won Two Film Festival Awards for His Movie About Stroke
Directed by critical care doctor Renyu Liu, Wake Up Stroke 120 won Best Short Narrative Film and the Humanitarian Award at this year’s New York City International Film Festival.
Philly Pharmacologists Are Developing a Promising Pain-Relieving CBD Analog Drug
Scientists from Temple’s Lewis Katz School of Medicine and local biopharma company Neuropathix are testing their compound, KLS-13019, which is intended to target chemotherapy-induced pain in cancer patients.
What We Learned at Philly Tech Week’s Cell and Gene Therapy Night
From why Philly is a great place to start a life sciences company to the ways the industry can be more inclusive, here’s what the experts had to say during this year’s virtual Philly Tech Week.
NextUp: The Philly Biotech Company Advancing Cancer Cell Therapy Through Bone Marrow
WindMIL Therapeutics is targeting marrow-infiltrating lymphocytes (MILs) to create a treatment to destroy cancer cells in patients, no matter their tumor type.
Everything You Need to Know About the Pfizer Vaccine and Kids, According to an Epidemiologist
The FDA is expected to expand emergency use of the Pfizer COVID-19 vaccine to adolescents as young as 12.
Rutgers Engineers Are Developing a Breathalyzer Test for COVID-19
The fast-acting sensor is designed to identify the presence of SARS-CoV-2 from exhaled breath in 10 minutes.
Local Biopharma Company Immunome Is Developing an “Antibody Cocktail” to Fight COVID-19 Variants
Composed of three monoclonal antibodies, Immunome’s IMM-BCP-01 has demonstrated strong performance in preclinical testing.